Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
Study NCT ID:
NCT06351020
Status:
RECRUITING
Last Update Posted:
2025-09-12
First Post:
2024-03-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.
Sponsor:
LaNova Medicines Zhejiang Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-24
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-15
First Submit QC Date:
None
Study First Post Date:
2024-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-07
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED